An Open-label, Multicenter Study to Assess the Pharmacokinetics (PK), Safety, and Tolerability of Subcutaneous IgPro20 in Immunoglobulin (IG) Treatment-naïve Participants With Primary Immunodeficiency (PID)
Clinical trial NCT07076446 · COMPLETED
Trial details
- NCT number
- NCT07076446
- Sponsor
- CSL Behring
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-15
- Primary completion
- 2026-06-30
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.